Search Results 641-650 of 17316 for Conduction

1. A Clinical Study To Test How Effective And Safe GLPG1690 Is For Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment

   Clinically significant abnormalities detected on ECG of either rhythm or conduction, a QTcF > 450 ms, or a known long QT syndrome. Currently taking ...

2. Endocrinology - Clinical trials

   [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

3. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

   Severe uncontrolled ventricular arrhythmias or electrocardiographic evidence of active conduction system abnormalities; Cardiac amyloidosis with hypotension ...

4. Publications - Xiaoning Ding, Ph.D. - Mayo Clinic

   Ding X, Younkin JE, Shen J, Bues M, Liu W. A critical review of the practices of proton daily quality assurance programs. Ther Radiol Oncol. 2021 Dec; 5:22.

5. Arthritis - Doctors and departments - Mayo Clinic

   ... conduction study, Injection, Osteoarthritis, Back pain, Cervical myelopathy, Neck pain, Brachial plexus injury, Herniated disk, Arthritis, Bursitis ...

6. Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

   ... conduction system abnormalities; NOTE: prior to study entry, any electrocardiogram (ECG) abnormality at screening has to be documented by the investigator ...

7. Endocrinology - Doctors - Mayo Clinic

   Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

8. Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

   ... conduction system abnormalities; NOTE: Prior to study entry, any electrocardiogram (ECG) abnormality at screening has to be documented by the investigator ...

9. Study to Evaluate the Safety, Tolerability and Preliminary Antitumor Activity of INCB059872 in Patients with Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

   For participants with an intraventricular conduction delay (QRS interval ≥ 120 ms), the JTc interval may be used in place of the QTc with sponsor approval.

10. IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome - Mayo Clinic

    ... conduction system abnormalities. Prior to study entry, any ECG abnormality at screening has to be documented by the investigator as not medically relevant ...